Skip to main content

Roche to acquire Telavant Holdings for $7.1bn

Roche will get the rights to manufacture and commercialise a 'promising' new treatment for inflammatory bowel disease under this new deal.


Read more: Roche to acquire Telavant Holdings for $7.1bn


https://bit.ly/45Hv2Sb

Popular posts from this blog

Whitespace’s R&D investment in new AI software pays off

The research, design and engineering company has won two multimillion-pound contracts following investment in R&D. The post Whitespace’s R&D investment in new AI software pays off appeared first on Silicon Republic. https://bit.ly/2TwxsDy

Statkraft aims for 3GW of Irish renewable projects by 2030

The energy company said this roadmap includes 1.5GW of Irish projects that have been built or are already under construction. Read more: Statkraft aims for 3GW of Irish renewable projects by 2030 https://bit.ly/3SC1FfJ

Carlow cloud start-up Stryve invests €1m in UK expansion

The expansion comes after Stryve made some high-profile tenders in the UK since its founding in 2018. The post Carlow cloud start-up Stryve invests €1m in UK expansion appeared first on Silicon Republic. https://bit.ly/3Hhk3U6